The FDA has granted a landmark approval to an intravenous injection for the imaging of tau pathology among patients with cognitive impairment being evaluated for Alzheimer disease.
In this podcast, Dr Lee discusses available data on the use of remdesivir for the treatment of severe COVID-19, and how the FDA's emergency authorization of remdesivir will impact the care of hospitalized...
This roundup of COVID-19 news includes results of a phase 2 trial of an antiviral triple therapy, the first antigen test authorized by the FDA, pneumonia guidelines, COVID-19–related illness in children,...
It is the first sodium-glucose co-transporter 2 inhibitor to be approved to treat adults with New York Heart Association’s functional class II-IV heart failure with reduced ejection fraction.
This roundup of COVID-19 stories includes details on a new serological assay, recommendations for the treatment of patients with diabetes during the pandemic, and an FDA warning on the use of...
The US Food and Drug Administration have approved the first generic of albuterol sulfate inhaler, for the treatment and prevention of bronchospasm in patients with reversible obstructive airway disease who...
The US Food and Drug Administration has announced that it is requesting that manufacturers withdraw all prescription and over-the-counter ranitidine drugs (Zantac) immediately.
A roundup of COVID-19 news, including potential treatment options, new guidance from the CDC and IDSA, and statements from the FDA on testing and the use of NSAIDs.
The US Food and Drug Administration have approved a supplemental application for a hepatitis C treatment option to include treatment of hepatitis C virus (HCV) in children aged 6 years and older.
